PATENT CLAIM ANALYSIS

Application Number: 15874718
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "085200"]

Abstract:
The present invention provides improved and/or shortened methods for expanding TILs and producing therapeutic populations of TILs, including novel methods for expanding TIL populations in a closed system that lead to improved efficacy, improved phenotype, and increased metabolic health of the TILs in a shorter time period, while allowing for reduced microbial contamination as well as decreased costs. Such TILs find use in therapeutic treatment regimens.

Claim (Index 8):
The method according to  claim 1 , wherein prior to administering a therapeutically effective dosage of TIL cells in step (h), a non-myeloablative lymphodepletion regimen has been administered to the subject.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.41176
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15800967', '14917214', '14205069', '12869390', '13876198']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7469935310196257
- 35 USC 102 Novelty (BERT): 0.5275526342451812
- Combined Prediction Score: 0.7250494413421813
- Mean Citation Score: 307.25695800000005
- Max Citation Score: 338.64148
- Similarity Product: 224.5090028929901

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test